Kyverna Therapeutics, Inc., a biopharmaceutical company based in Emeryville, California, announced that it will present topline results from its registrational Phase 2 clinical trial, known as...
Kyverna Therapeutics, Inc. has announced plans to present topline results from its registrational Phase 2 clinical trial, known as KYSA-8, assessing the efficacy of its investigational...
The Rowan-Salisbury School Board has approved crucial contracts for the upcoming J.H. Knox Intermediate School, including a significant agreement for furniture and athletic equipment. On March...
The Rowan-Salisbury School Board made significant decisions during its recent meeting, approving contracts for furniture and athletic equipment for the new J.H. Knox Intermediate School. The...
Herriot Tabuteau, the Chief Executive Officer of Axsome Therapeutics, Inc. (NASDAQ: AXSM), has sold 49,252 shares of the company’s stock in a transaction on December 2,...
Axsome Therapeutics, Inc. has announced that its CEO, Herriot Tabuteau, sold 49,252 shares of the company’s stock on December 2, 2023. The shares were sold at...
On November 24, 2023, Bioventures 2014 L.P. Mpm, a significant shareholder of Werewolf Therapeutics, Inc. (NASDAQ: HOWL), sold 88,802 shares of the company. The shares were...
Aclarion, Inc. (NASDAQ: ACON), a healthcare technology company, is currently assessing its standing among competitors in the Medical Services industry. This analysis evaluates Aclarion’s performance in...
Aclarion, Inc. (NASDAQ: ACON) has emerged as a notable player in the “Medical Services” sector, which comprises 93 publicly traded companies. A recent financial survey provides...
The Yale chapter of Delta Sigma Theta Sorority, Inc. recently engaged the community with a week-long series of events known as the “REDaissance,” celebrating its annual...
